| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.62▼ | 3.61▲ | 3.64▼ | 3.75▼ | 3.74▼ |
| MA10 | 3.62▼ | 3.65▼ | 3.67▼ | 3.65▼ | 4.49▼ |
| MA20 | 3.65▼ | 3.70▼ | 3.72▼ | 3.83▼ | 5.15▼ |
| MA50 | 3.71▼ | 3.79▼ | 3.72▼ | 4.57▼ | 6.96▼ |
| MA100 | 3.75▼ | 3.70▼ | 3.72▼ | 5.44▼ | 4.62▼ |
| MA200 | 3.83▼ | 3.79▼ | 4.39▼ | 7.24▼ | 3.57▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.008▼ | -0.021▼ | 0.031▲ | -0.153▼ |
| RSI | 37.245▼ | 39.007▼ | 41.542▼ | 39.282▼ | 35.467▼ |
| STOCH | 68.452 | 11.830▼ | 15.269▼ | 58.588 | 20.270 |
| WILL %R | -78.571▼ | -89.655▼ | -95.522▼ | -67.647 | -90.178▼ |
| CCI | -23.333 | -74.759 | -92.369 | -24.565 | -110.921▼ |
|
Wednesday, October 07, 2026 09:08 AM
Issued patents provide intellectual property protection for clinical candidates, AP-SA02 and AP-PA02, until at least 2041. LOS ANGELES, Oct. 7, 2026 // -- Armata Pharmac ...
|
|
Monday, September 21, 2026 04:00 AM
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity and potency, pathogen-specific ...
|
|
Monday, September 14, 2026 04:03 AM
Designation is driven by compelling Phase 2 clinical data in patients with complicated Staphylococcus aureus bacteremia showing AP-SA02 may offer substantial improvement over available therapies ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/10/26 | 3.74 | 3.74 | 3.595 | 3.61 | 41,445 |
| 09/10/26 | 3.90 | 3.95 | 3.62 | 3.63 | 100,600 |
| 08/10/26 | 3.79 | 3.91 | 3.59 | 3.86 | 70,300 |
| 07/10/26 | 3.83 | 4.07 | 3.72 | 3.81 | 103,600 |
| 06/10/26 | 3.69 | 3.93 | 3.66 | 3.85 | 114,600 |
| 05/10/26 | 3.54 | 3.68 | 3.51 | 3.66 | 56,619 |
| 02/10/26 | 3.40 | 3.55 | 3.32 | 3.52 | 123,852 |
| 01/10/26 | 3.67 | 3.78 | 3.28 | 3.31 | 76,367 |
| 30/09/26 | 3.57 | 3.74 | 3.53 | 3.67 | 127,027 |
| 29/09/26 | 3.74 | 3.74 | 3.52 | 3.59 | 91,800 |
|
|
||||
|
|
||||
|
|